Observational studyFrontiers in endocrinology2025
Differential Effects of First and Third Trimester HbA1c Levels on Neonatal Weight and Placental Mediation in Type 1 Diabetes.
Observational study in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Predictive value of glycated hemoglobin levels for large for gestational age infants in women with pregestational diabetes according to body mass index.Obstetrics & gynecology science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Context: In women with type 1 diabetes (T1D), the effects of glycaemic control on neonatal weight and the role of the placenta are not fully understood. Objective: This study explores the relationship between glycaemic control, neonatal weight, and placental weight. Design: A retrospective observational longitudinal study of pregnant women with T1DM. Setting: The study included 265 women with T1D. The target for the first A1c was set at ≤ 7.0%, while the target for the last A1c was ≤ 6.5%. The cohort was divided into four groups based on whether they achieved their target A1c (T) or had levels higher than the target (H) at each end. These groups were classified as Target-Target (T-T), Target-High (T-H), High-Target (H-T), and High-High (H-H). For the secondary objective, we included 154 women for whom placental weight data were available. Main outcome: We assessed the association between firstA1c, lastA1c, and neonatal weight, examining the mediation effect of the placenta. Results: The mean age of the participants was 29.4 years (SD 4.6), and the mean T1DM duration was 14.1 years (SD 7.1). The median neonatal weight was highest in the T-H group (3.56 kg) and lowest in the H-T group (3.20 kg) (p=0.009). FirstA1c was negatively correlated with neonatal weight (β-coefficient -150.9, p < 0.01), whereas lastA1c positively correlated (β-coefficient 162.5, p < 0.01). The association with firstA1c disappeared when correcting for placental weight, while lastA1c remained significant. The placenta mediates 65% of the impact of firstA1c on neonatal weight. Conclusions: Poor glycaemic control early in pregnancy is linked to lower neonatal birth weight, while poor control in the third trimester is associated with higher birth weight. These findings emphasize the importance of maintaining adequate glycaemic control before and during early pregnancy for better health outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.